CTSO vs HUBS · rev $18.5M vs P/E 96, rev $1.79B
Cytosorbents Crp (CTSO) versus HubSpot Inc (HUBS) — a side-by-side from cached financials, not a winner call.
Cytosorbents Crp (CTSO) is a medical devices company listed on US.
HubSpot Inc (HUBS) is a software - application company listed on NYSE.
Latest reported CTSO revenue for 2026-06-30 was $18.5M. Net income was -$9.5M. CTSO currently screens at market cap $28.8M.
Latest reported HUBS revenue for 2026-06-30 was $1.79B. Net income was $75.9M. HUBS currently screens at market cap $9.36B and trailing P/E 96.2.
CTSO currently screens at market cap $28.8M. HUBS currently screens at market cap $9.36B and trailing P/E 96.2.
Not investment advice. Open the CTSO and HUBS stock pages for the full models.
Not investment advice.